BRE Commissions Pilot Plant Co-Funding Secured For Stage II Hydromet Pilot Plant
| STAGE I – BENEFICIATION Upgrades Rocha da Rocha mineral feedstocks into mineral concentrate for downstream pilot testing and PFS engineering | STAGE II - HYDROMETALLURGY Converts mineral concentrate into value-add products, optimising extraction and separation flowsheets, and generating data for a Camaçari rare earth refinery |
TECHNICAL PARTNERS SUPPORT EXECUTION
SENAI CIMATEC combines applied research, industrial technology and technical education. The partnership will build pilot plant processing and analytical capability at Camaçari, supporting technical jobs and specialist skills development in Bahia, Brazil.
Carester, the French rare earth separation specialist, will lead the separation workstream across the pilot program and PFS, and support engineering, design and commissioning for the planned Camaçari refinery.
Carester is also BRE's heavy rare earth HRE+ concentrate offtake partner under a binding sales agreement with an initial 10-year term, covering product containing up to 150 tonnes per annum of dysprosium and terbium. Carester's HRE+ concentrate offtake will be processed at their Caremag facility in France into separated heavy rare earths including dysprosium, terbium and yttrium oxides.2
Figure 1: BRE Metallurgical Pilot Plant Team.
STRATEGIC CO-PRODUCT VALUE STREAMS
BRE's co-product program will advance metallurgical test work using leach solutions and residues generated during piloting to optimise recovery of uranium, scandium, niobium, titanium and tantalum.
The August 2026 Scoping Study places Monte Alto + Camaçari in the first quartile of Benchmark Mineral Intelligence's forecast global rare earth cost curve at approximately US$21/kg NdPr equivalent.3 That cost position excludes the potential credits from uranium, scandium and Nb-Ta-Ti strategic co-products.
The economic opportunity is to recover additional payable products from material scheduled to be mined and processed for rare earths. Commercial receipts, after additional recovery and selling costs, could offset a greater proportion of the operation's costs and reduce net NdPr-equivalent unit costs below the Scoping Study benchmarks.
The Scoping Study includes all forecast uranium recovery and yellowcake capital and operating costs while assigning no uranium revenue. Subject to a commercial framework, value realised from this uranium co-product could provide a significant source of cost credits. Uranium value realisation remains subject to applicable Brazilian requirements and agreed commercial arrangements with INB.
Successful development of these pathways could strengthen BRE's position among the world's lowest-cost rare earth development projects. The PFS program will assess the technical and commercial parameters to quantify the economic potential.
| Co-product | Published basis | Focus of further work |
| Uranium | 540 tpa U3O8 in the first five run-rate years; 466 tpa LOM average. Capex and recovery costs included; revenue excluded. | Yellowcake product, integrated performance and commercial value retained by BRE. |
| Scandium | Study-estimated annual feed inventory of ~43 tonnes Sc2O3 LOM average, before metallurgical recovery; no production or revenue included. | Extraction from solution, purification, product quality, incremental costs and customer partnerships. |
| Tantalum, niobium, titanium | Potential recovery from enriched leach residues; no production or revenue included. | Residue upgrading, critical element recoveries, saleable products and buyer payability. |
Source: 18 August 2026 Scoping Study update, pages 4, 15, 19–20. Average annual scandium content is a feed-inventory estimate before metallurgical recovery, not saleable scandium production. No annual niobium, tantalum or titanium production estimate is presented.
NEXT STEPS
- Optimise Stage I: Systematic variability test work to optimise processing routes, refine mineral concentrate grade and recovery, and generate feedstock for downstream metallurgical programs Deliver Stage II: Complete and commission the hydrometallurgical pilot plant in Q2 2027, for planned integrated extraction and rare earth separation programs Expand analytical capability: Install dedicated laboratory equipment for rapid multi-element analysis to support process optimisation and product-quality testing Monte Alto fast-track pathway: Pilot results will support the assessment of the potential fast-track Monte Alto ungraded mineral concentrate development pathway, subject to further engineering and technical studies Strategic co-product development: Metallurgical test work programs, flowsheet design and product samples for potential uranium, scandium, niobium, titanium and tantalum co-products Apply the results: Incorporate pilot plant data into the PFS engineering, flowsheet design, equipment selection and product samples for customer evaluation and offtake discussions
A link to the complete announcement can be found: here
Contacts
Bernardo Da Veiga
Managing Director and CEO
...
________________________________________________
1SENAI CIMATEC has partnered with EMBRAPII (Brazilian public-private partnership focused on fostering technological research and industrial innovation) to provide the R$6.4m (~A$1.7m) in funding.
Note: References to the Scoping Study mean the standalone Integrated Monte Alto + Camaçari Case released on 18 August 2026. Co-product benefits remain subject to recovery, product quality, costs and commercials. No revised cost forecast or global cost ranking is reported.
2 Refer to BRE's ASX announcement dated 9 October 2025,“BRE Signs Rare Earths Offtake & Partnership with Carester”.
3 BRE confirms that the material assumptions supporting the production targets and associated financial forecasts in its 18 August 2026 announcement remain applicable and have not materially changed.
A photo accompanying this announcement is available at

Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept any
responsibility or liability for the accuracy, content, images, videos,
licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright issues
related to this article, kindly contact the provider above.


Comments
No comment